arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

IMMUNIC, INC.

IMUX

$9.40 ▼ -1.42 (-13.12%) at close

15 Visible periods

21 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Moderately Bullish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, IMMUNIC, INC. shows strong fundamentals, led by Return on Invested Capital. Watch FCF / Net Income against typical quality thresholds. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $1.5B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 1222.1% ↗

FCF / Share $-0.55 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-97.17M

↑ +3.3% —

FCF / Share Free cash flow per share

$-0.55

↑ +34.9% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 1222.1% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.88x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality →

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2014

FY 2015

FY 2016

FY 2017

$0.00

FY 2018

$0.00

FY 2019

FY 2020

$0.00

FY 2021

$0.00

FY 2022

$0.00

FY 2023

$0.00

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
EPS Growth YoY (%)	38.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	52.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	44.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	3.8% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	-39.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	3.3% Caution ↑ Caution Improving Year-over-year change in net income	-7.4% Weak ↑ Weak Improving Year-over-year change in net income	22.3% Good ↑ Good Improving Year-over-year change in net income	-29.5% Weak ↑ Weak Improving Year-over-year change in net income	-111.2% Weak ↓ Weak Declining Year-over-year change in net income	-26.0% Weak ↑ Weak Improving Year-over-year change in net income	-202.7% Weak ↓ Weak Declining Year-over-year change in net income	77.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-27.1% Weak ↓ Weak Declining Year-over-year change in net income	21.2% Good ↑ Good Improving Year-over-year change in net income	-9.1% Weak ↑ Weak Improving Year-over-year change in net income	-45.7% Weak Weak Year-over-year change in net income	-388.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	34.9% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	47.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	21.7% Good ↑ Good Improving Year-over-year change in free cash flow	41.8% Excellent Excellent Year-over-year change in free cash flow	-19.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
FCF / Net Income (x)	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	1222.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-420.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-270.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-83.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	36.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-83.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-50.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	55.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	99.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-429.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-239.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-182.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-93.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-65.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-56.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-89.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-87.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-64.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-46.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-67.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	—	—	-105.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-806%)	-73.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-587%)	-27.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-59.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-499%)	44.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+199%)	-104.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-794%)	-70.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-567%)	-63.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-521%)	-48.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-426%)	73.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+388%)	87.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+485%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	-23.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-15.48M	$-35.67M	$-46.67M	$-106.75M	$-86.86M	$-127.45M	$-29.37M	$-13.07M	$-56.90M	$-59.99M	$-83.42M	$-102.24M	$-38.19M	$-4.48M	$-803.00K

📊 What does each share earn? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Basic EPS, GAAP (USD)	$-0.62	$-1.00	$-2.11	$-3.78	$-3.93	$-2.81	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.55	$-0.85	$-1.61	$-2.05	$-3.52	$-2.95	—	—	—	—	—	—	—	—	—
Dividend per Share (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.07	$0.20	$0.64	$2.89	$4.83	$7.50	$5.43	$-30.39	$47.25	$72.73	$108.06	$162.72	$-2.95K	—	—
Tangible Book Value per Share (USD)	$-0.07	$0.20	$0.64	$2.89	$3.57	$5.94	$2.36	$-30.39	$47.25	$72.73	$108.06	$162.72	$-2.95K	—	—
Basic Weighted Avg Shares (shares)	155.69M	100.17M	44.32M	31.82M	23.65M	15.66M	—	—	—	—	—	—	—	—	—
Dividend Payout Ratio (%)	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$-7.75M	$17.16M	$27.80M	$112.79M	$93.59M	$125.35M	$25.16M	$11.41M	$47.84M	$55.98M	$78.43M	$94.54M	$36.41M	—	—
Total Equity (USD)	$-6.67M	$18.43M	$28.93M	$113.68M	$127.11M	$158.78M	$58.36M	$-25.74M	$50.04M	$58.45M	$82.33M	$97.56M	$-44.66M	$-7.63M	$-54.85M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Depreciation Expense (USD)	$168.00K	$134.00K	$111.00K	$77.00K	$85.00K	$39.00K	$50.00K	$15.00K	$998.00K	$1.81M	$1.33M	$1.09M	$799.00K	$651.00K	—
Net Income, GAAP (USD)	$-97.17M	$-100.51M	$-93.61M	$-120.41M	$-92.94M	$-44.02M	$-34.93M	$-11.54M	$-52.08M	$-40.97M	$-52.02M	$-47.67M	$-32.72M	$-6.70M	—
Operating Cash Flow (USD)	$-85.81M	$-84.77M	$-70.83M	$-65.14M	$-83.23M	$-46.12M	$-28.55M	$-9.74M	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 15 years · 56 quarters

IMMUNIC, INC.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare IMUX with peers